FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age
Links shared publicly online about this topic.
- 541total visits
FDA approves the Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age
View full resource at novartis.com
Tags: Vaccination, Children's Health, FDA, Vaccine, Novartis
Most Recently Shared on January 31, 2011 at 2:19 pm By:
FDA approves Novartis quadrivalent meningococcal conjugate vaccine, Menveo®, for use in children from 2 years of age - http://ow.ly/3NfGW
Therapeutics Daily
therapeuticsdaily.com — “Therapeutics Daily” View full resource at therapeuticsdaily.com
Most Recently Shared on February 1, 2011 at 8:33 pm By:
PharmaLive Pharma and Health News
Therapeutics Daily - FDA Approves the Novartis Quadrivalent Meningococcal Conjugate Vaccine - http://tinyurl.com/4edah4a
Menveo meningococcal vaccine approved for children - ONA
oncologynurseadvisor.com — “Novartis announced that the FDA has approved Menveo (meningococcal [Groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in children 2--10 years of age.” View full resource at oncologynurseadvisor.com
Most Recently Shared on February 1, 2011 at 4:17 pm By:
OncologyNurseAdvisor Medical Publisher, Oncology, Nursing, and Medical Education
Menveo meningococcal vaccine approved for children http://goo.gl/fb/UUtBV
Menveo meningococcal vaccine approved for children - MPR
empr.com — “Novartis announced that the FDA has approved Menveo (meningococcal [Groups A, C, Y and W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in children 2--10 years of age.” View full resource at empr.com
Most Recently Shared on February 1, 2011 at 3:43 pm By:
MPR News: Menveo meningococcal vaccine approved for children: Novartis announced that the FDA has approved Menve... http://bit.ly/eJpIuF
Health Canada approves Novartis' Menveo for prevention of meningococcal disease
news-medical.net — “Novartis Pharmaceutical Canada Inc. announced that Menveo (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by Health Canada for active immunization of adolescents (11 to 18 years of age) and adults (19 to 55 years of age) to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135.” View full resource at news-medical.net
Most Recently Shared on June 8, 2010 at 6:19 pm By:
Meningitis News: Health Canada approves Novartis' Menveo for prevention of meningococcal disease: Novartis Pharmac... http://bit.ly/cktD6u
Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease
novartis.com — “Novartis receives approval in the European Union for Menveo, first quadrivalent conjugate vaccine in the EU to help prevent meningococcal disease” View full resource at novartis.com
Most Recently Shared on March 18, 2010 at 7:14 am By:
Novartis Menveo is 1st quadrivalent conjugate vaccine approved in EU to help prevent meningococcal disease: http://bit.ly/cbKt7t
Novartis Receives FDA Approval Of Menveo®, A Vaccine To Prevent Meningococcal Disease
medicalnewstoday.com — “Novartis announced that Menveo® (Meningococcal (Groups A, C, Y and W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine), a quadrivalent meningococcal conjugate vaccine was approved by t” View full resource at medicalnewstoday.com
Most Recently Shared on February 23, 2010 at 10:10 pm By:
MNT Clinical Trials Health News
Novartis Receives FDA Approval Of Menveo®, A Vaccine To Prevent Meningococcal Disease http://mnt.to/3xY6 #clinicaltrials
New vaccine approved to prevent meningococcal disease
pediatricsupersite.com — “FDA officials have approved Novartis' quadrivalent meningococcal conjugate vaccine to prevent invasive meningococcal disease caused by Neisseria” View full resource at pediatricsupersite.com
Most Recently Shared on February 23, 2010 at 3:00 pm By:
Pediatric SuperSite Health Site
New vaccine approved to prevent #meningococcal disease: http://ow.ly/1ak18 #Menveo #Novartis
Menveo vaccine approved for meningococcal disease immunization - MPR
empr.com — “Novartis announced that the FDA has approved Menveo (meningococcal [Groups A, C, Y, W-135] oligosaccharide diphtheria CRM197 conjugate vaccine) for the active immunization against invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135 in people 11"55 years of age.” View full resource at empr.com
Most Recently Shared on February 22, 2010 at 5:38 pm By:
MPR News: Menveo vaccine approved for meningococcal disease immunization: Novartis announced that the FDA has appr... http://bit.ly/arjEnf
Advertisement
